Some may think I continue to see things through rose coloured glasses , but for mine ,if the company has the ability to see EFTI through to a breakthrough designation or accelerated approval status , this creates the optimal timing for a collaboration licensing deal or buyout, if the data continues to impress and the company has the belief and funds to reach these expedited commercial routes ,why sell yourself short(to make a quick buck).
With Wayne Hohlman as a substantial shareholder and for mine having a large say in the companies future, I don’t believe that was ever going to be the case.
Some may think I continue to see things through rose coloured...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.020(7.41%) |
Mkt cap ! $421.8M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 29.5¢ | 27.0¢ | $1.138M | 3.985M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 63444 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 65000 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |